(Q74023445)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

A Saleem

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Osman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

F Brady

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

B Suttle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S V Lucas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

T Jones

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P M Price

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E O Aboagye

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

9221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

2125-2131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Fluorouracil: biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Intra- and extracellular fluorouracil uptake: assessment with contrast-enhanced metabolic F-19 MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

5-Ethynyluracil (776C85): protection from 5-fluorouracil-induced neurotoxicity in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

5-Ethynyluracil (776C85): inactivation of dihydropyrimidine dehydrogenase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Uptake of neutral alpha- and beta-amino acids by human proximal tubular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902380-1

7 January 2021

10.1016/S0140-6736(00)02380-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10902627%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference